EWNYSESEC EDGAREDGAR

Edwards Lifesciences Corp

Orthopedic, Prosthetic & Surgical Appliances & Supplies·IRVINE, CA·FY end 12/31·CIK 1099800
CEO Pay Ratio
194:1
Mr. Zovighian
CEO Total Comp
$17.5M
Mr. Zovighian
Median Employee
$89,827
Revenue
$6.1B
FY 2025
Net Income
$1.1B
FY 2025
Free Cash Flow
$1.3B
FY 2025
Net Margin
17.7%
Insider Net (180d)
-$14.6M
0 buys / 26 sales

CEO Pay Accountability

CEO comp as % of net income
1.63%
For every $1,000 of profit, $16.26 flows to the CEO.
CEO comp as % of buybacks
1.95%
CEO comp equals 19.5‰ of cash returned to shareholders via buybacks.

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$6.1B$1.4B$6.0B$5.4B$5.2B
Gross Profit$4.7B$1.1B$4.6B$4.3B$4.0B
Operating Income$1.3B$1.4B$1.5B$1.7B$1.7B
Net Income$1.1B$385.6M$1.4B
Operating CF$1.6B$542.3M$895.8M$1.2B$1.7B
Capex$260.2M$252.4M$253.0M$244.6M$325.8M
Free Cash Flow$1.3B$289.9M$642.8M$973.6M$1.4B
Buybacks$893.4M$1.2B$879.6M$1.7B$512.8M
Dividends
Gross Margin78.0%78.9%77.0%79.9%76.1%
Operating Margin20.8%99.5%25.5%32.5%32.3%
Net Margin17.7%27.8%23.4%
FCF Margin22.0%20.9%10.7%18.1%26.9%
R&D / Revenue17.8%76.0%17.8%17.6%17.3%
Effective Tax17.0%9.8%12.4%13.9%11.7%
Debt / Equity0.060.060.090.100.10
Buybacks / FCF66.9%399.9%136.8%177.4%36.5%

Named Executive Officers

FY 2025
ExecutiveSalaryStockOptionsBonus / Inc.OtherTotal
Mr. ZovighianChief Executive Officer and Director
$1.2M$7.2M$6.5M$2.4M$189.1K$17.5M
Mr. UllemCorporate Vice President, Chief Financial Officer
$807.9K$2.2M$2.0M$966.4K$71.3K$6.1M
Mr. WoodFormer Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart
$635.9K$1.8M$1.6M$689.4K$61.8K$4.9M
Mr. ChopraCorporate Vice President, Transcatheter Mitral and Tricuspid Therapies
$671.0K$1.8M$1.4M$824.2K$60.6K$4.7M
Mr. BoboCorporate Vice President, Strategy & Corporate Development
$759.8K$1.4M$1.2M$786.9K$48.6K$4.2M
Ms. Brüls
$726.6K$1.0M$925.0K$719.6K$340.6K$3.7M